Magnesium orotate

Magnesium orotate
Clinical data
AHFS/Drugs.com	Consumer Drug Information
ATC code	A12CC09 ( WHO );
Identifiers
	IUPAC name magnesium 2,6-dioxo-3H-pyrimidine-4-carboxylate;
CAS Number	34717-03-8 ;
PubChem CID	3036905 ;
ChemSpider	2300801 ;
UNII	GI96W46M5A ;
CompTox Dashboard (EPA)	DTXSID20905129 ;
ECHA InfoCard	100.047.410
Chemical and physical data
Formula	C10H6MgN4O8
Molar mass	334.483 g·mol−1
3D model (JSmol)	Interactive image ;
	SMILES [Mg+2].O=C([O-])\C1=C\C(=O)NC(=O)N1.[O-]C(=O)\C1=C\C(=O)NC(=O)N1;
	InChI InChI=1S/2C5H4N2O4.Mg/c28-3-1-2(4(9)10)6-5(11)7-3;/h21H,(H,9,10)(H2,6,7,8,11);/q;;+2/p-2; Key:QWLHYYKDLOVBNV-UHFFFAOYSA-L;
	(verify)

Last updated January 11, 2026

Magnesium orotate, the magnesium salt of orotic acid, is a mineral supplement. It can be used in treating extracellular magnesium deficiency, as well as in mitigating magnesium depletion that inhibits the binding of adenosine triphosphate via orotic acid, which provides binding sites.^[1]

References

↑ Classen HG (2004). "Magnesium orotate--experimental and clinical evidence". Romanian Journal of Internal Medicine. 42 (3): 491–501. PMID 16366126.

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[1] Classen HG (2004). "Magnesium orotate--experimental and clinical evidence". Romanian Journal of Internal Medicine. 42 (3): 491–501. PMID 16366126.

[1]